Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF Cash-to-Debt is 12.16 as of Sep. 2025, which is 19% below its 10-year median of 15.07. The stock has 4 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Reflect Scientific ranks better than 76.09% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Reflect Scientific's cash to debt ratio for the quarter that ended in Sep. 2025 was 12.16.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Reflect Scientificcould pay off its debt using the cash in hand for the quarter that ended in Sep. 2025.
The historical rank and industry rank for Reflect Scientific's Cash-to-Debt or its related term are showing as below:
RSCF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 2.3 Med: 15.07 Max: No Debt
Current: 12.16
During the past 13 years, Reflect Scientific's highest Cash to Debt Ratio was No Debt. The lowest was 2.30. And the median was 15.07.
RSCF's Cash-to-Debt is ranked better than 76.09% of 845
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs RSCF: 12.16
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Reflect Scientific Cash-to-Debt Related Terms
Reflect Scientific Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reflect Scientific (RSCF) has a Cash-to-Debt of 12.16 as of Sep. 2025. This is 19% below median its historical median of 15.07. Over the past decade, Reflect Scientific's Cash-to-Debt has ranged from 2.30 to 10,000.00. According to the industry distribution chart, Reflect Scientific ranks #202 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 23.9%.
Is Reflect Scientific's Cash-to-Debt too high?
Reflect Scientific's current Cash-to-Debt of 12.16 is 19% below median its 10-year median of 15.07. Over the past 10 years, this metric has ranged from a low of 2.30 to a high of 10,000.00. The Medical Devices & Instruments industry median Cash-to-Debt is 1.68. Reflect Scientific's value of 12.16 is 623.8% above this industry median. Based on the distribution chart, Reflect Scientific ranks #202 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Reflect Scientific's Cash-to-Debt compare to NXGL and YBGJ?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #202 out of 845 companies for Cash-to-Debt. This places Reflect Scientific in the top 24% of its industry — outperforming the majority of peers. The industry median Cash-to-Debt is 1.68. Reflect Scientific's value of 12.16 is 623.8% above this benchmark. Historically, Reflect Scientific's own Cash-to-Debt has ranged from 2.30 to 10,000.00 over the past decade. While the company's 10-year median is 15.07 vs. the industry median of 1.68, Reflect Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.68, based on 845 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Cash-to-Debt of 12.16 is 623.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Cash-to-Debt is 12.16, which is 19% below median its own 10-year median of 15.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Cash-to-Debt of 12.16. The current Cash-to-Debt is 12.16, which is 19% below median its 10-year median of 15.07 and 623.8% above the Medical Devices & Instruments industry median of 1.68. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Cash-to-Debt is 12.16 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
